These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 2751365)
1. The contribution of immunohistochemistry to the differential diagnosis of primary and metastatic neoplasma of the central nervous system (CNS). Markaki S; Prevedorou D; Georgoulakis G; Bouja J; Karabela-Bouropoulou V Arch Anat Cytol Pathol; 1989; 37(3):93-8. PubMed ID: 2751365 [TBL] [Abstract][Full Text] [Related]
2. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors. Molenaar WM; Jansson DS; Gould VE; Rorke LB; Franke WW; Lee VM; Packer RJ; Trojanowski JQ Lab Invest; 1989 Dec; 61(6):635-43. PubMed ID: 2557487 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical differential diagnosis of benign cysts in the central nervous system. Morimura T; Maeda Y; Tani E; Nishigami T Noshuyo Byori; 1994; 11(1):7-13. PubMed ID: 7512867 [TBL] [Abstract][Full Text] [Related]
4. [Differential immunohistochemical diagnosis of tumors of the human central nervous system using monoclonal antibodies]. Vial'tseva IuIu; Bukhvalov IB; Vasilov RG Arkh Patol; 1996; 58(2):28-32. PubMed ID: 8712936 [TBL] [Abstract][Full Text] [Related]
5. Expression of cytokeratins in gliomas. Goswami C; Chatterjee U; Sen S; Chatterjee S; Sarkar S Indian J Pathol Microbiol; 2007 Jul; 50(3):478-81. PubMed ID: 17883112 [TBL] [Abstract][Full Text] [Related]
6. Value and limits of immunohistochemistry in differential diagnosis of clear cell primary brain tumors. Koperek O; Gelpi E; Birner P; Haberler C; Budka H; Hainfellner JA Acta Neuropathol; 2004 Jul; 108(1):24-30. PubMed ID: 15108012 [TBL] [Abstract][Full Text] [Related]
7. Ependymomas of the central nervous system and adult extra-axial ependymomas are morphologically and immunohistochemically distinct--a comparative study with assessment of ovarian carcinomas for expression of glial fibrillary acidic protein. Idowu MO; Rosenblum MK; Wei XJ; Edgar MA; Soslow RA Am J Surg Pathol; 2008 May; 32(5):710-8. PubMed ID: 18360284 [TBL] [Abstract][Full Text] [Related]
8. Polymorphous low-grade adenocarcinoma versus pleomorphic adenoma of minor salivary glands: resolution of a diagnostic dilemma by immunohistochemical analysis with glial fibrillary acidic protein. Curran AE; White DK; Damm DD; Murrah VA Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Feb; 91(2):194-9. PubMed ID: 11174597 [TBL] [Abstract][Full Text] [Related]
9. [Contribution of immunohistochemical methods to the study of central nervous system tumors]. Rubinstein LJ Ann Pathol; 1986; 6(3):157-63. PubMed ID: 3535816 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of cell surface antigens and glial fibrillary acidic protein in human astrocytoma subsets. Rettig WJ; Chesa PG; Beresford HR; Feickert HJ; Jennings MT; Cohen J; Oettgen HF; Old LJ Cancer Res; 1986 Dec; 46(12 Pt 1):6406-12. PubMed ID: 2877731 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry in the diagnosis of neoplasms of the central nervous system. Morrison CD; Prayson RA Semin Diagn Pathol; 2000 Aug; 17(3):204-15. PubMed ID: 10968706 [TBL] [Abstract][Full Text] [Related]
12. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms. Preusser M; Budka H; Rössler K; Hainfellner JA Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132 [TBL] [Abstract][Full Text] [Related]
13. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma. Pitman MB; Triratanachat S; Young RH; Oliva E Int J Gynecol Pathol; 2004 Jan; 23(1):58-64. PubMed ID: 14668552 [TBL] [Abstract][Full Text] [Related]
14. An immunocytochemical study of normal and abnormal human cerebrospinal fluid with monoclonal antibodies to glial fibrillary acidic protein. Trojanowski JQ; Atkinson B; Lee VM Acta Cytol; 1986; 30(3):235-9. PubMed ID: 3459324 [TBL] [Abstract][Full Text] [Related]
16. An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein (GFAP) and S-100 protein (S100P) in human brain tumors. Kimura T; Budka H; Soler-Federsppiel S Clin Neuropathol; 1986; 5(1):21-7. PubMed ID: 3512139 [TBL] [Abstract][Full Text] [Related]
18. Peripheral primitive neuroectodermal tumor with neuronal and glial differentiation: report of a case arising in suprarenal region. Chantranuwat C J Med Assoc Thai; 2001 Apr; 84(4):584-8. PubMed ID: 11460974 [TBL] [Abstract][Full Text] [Related]
19. HEA 125 and Ber EP4: two monoclonal anti-epithelial, non-cytokeratin antibodies distinguishing metastatic carcinomas from glial tumors. Gottschalk J; Jautzke G; Zimmer C; Cervós-Navarro J Clin Neuropathol; 1993; 12(2):68-72. PubMed ID: 7682900 [TBL] [Abstract][Full Text] [Related]
20. GFAP immunoreactivity and transcription in trigeminal and dental tissues of rats and transgenic GFP/GFAP mice. Byers MR; Maeda T; Brown AM; Westenbroek RE Microsc Res Tech; 2004 Dec; 65(6):295-307. PubMed ID: 15662620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]